Sonia Gaztambide Saenz-rekin lankidetzan egindako argitalpenak (28)

2024

  1. Association between exposure to air pollution and blood lipids in the general population of Spain

    European Journal of Clinical Investigation, Vol. 54, Núm. 2

2021

  1. Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study

    Scientific Reports, Vol. 11, Núm. 1

  2. Iodine Deficiency and Mortality in Spanish Adults: Di@bet.es Study

    Thyroid, Vol. 31, Núm. 1, pp. 106-114

  3. Thyroid hormone resistance index and mortality in euthyroid subjects: Di@bet.es study

    European journal of endocrinology, Vol. 186, Núm. 1, pp. 95-103

2020

  1. Incidence and regression of metabolic syndrome in a representative sample of the Spanish population: Results of the cohort di@bet.es study

    BMJ Open Diabetes Research and Care, Vol. 8, Núm. 1

  2. Incidence of diabetes mellitus in Spain as results of the nation-wide cohort di@bet.es study

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Ambient temperature and prevalence of diabetes and insulin resistance in the Spanish population: Di@bet.es study

    European Journal of Endocrinology, Vol. 180, Núm. 5, pp. 275-282

  2. Dairy product consumption and metabolic diseases in the Di@bet.es study

    Nutrients, Vol. 11, Núm. 2

2018

  1. Iron deficiency is associated with Hypothyroxinemia and Hypotriiodothyroninemia in the Spanish general adult population: Di@bet.es study

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Population-Based National Prevalence of Thyroid Dysfunction in Spain and Associated Factors: Study

    Thyroid, Vol. 27, Núm. 2, pp. 156-166

  2. Reference values for TSH may be inadequate to define hypothyroidism in persons with morbid obesity: Di@bet.es study

    Obesity, Vol. 25, Núm. 4, pp. 788-793

2016

  1. Low physical activity and its association with diabetes and other cardiovascular risk factors: A nationwide, population-based study

    PLoS ONE, Vol. 11, Núm. 8

  2. Prevalencia, diagnóstico, tratamiento y control de la hipertensión arterial en España. Resultados del estudio Di@bet.es

    Revista Espanola de Cardiologia, Vol. 69, Núm. 6, pp. 572-578

2015

  1. Estimating cardiovascular risk in Spain by the European guidelines on cardiovascular disease prevention in clinical practice

    Revista Espanola de Cardiologia, Vol. 68, Núm. 5, pp. 417-425

  2. Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

    American Heart Journal, Vol. 169, Núm. 5, pp. 631-638.e7

2014

  1. Ambient temperature and prevalence of obesity in the spanish population: The di@bet.es study

    Obesity, Vol. 22, Núm. 11, pp. 2328-2332

  2. Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: The di@bet.es study

    Clínica e investigación en arteriosclerosis, Vol. 26, Núm. 3, pp. 107-114

  3. Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: The di@bet.es study

    Clinica e Investigacion en Arteriosclerosis, Vol. 26, Núm. 3, pp. 107-114

  4. Variable patterns of obesity and cardiometabolic phenotypes and their association with lifestyle factors in the Di@bet.es study

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 24, Núm. 9, pp. 947-955

2013

  1. Consumo de fármacos relacionados con el tratamiento de la diabetes mellitus y otros factores de riesgo cardiovascular en la población española. Estudio Di@bet.es

    Revista Espanola de Cardiologia, Vol. 66, Núm. 11, pp. 854-863